Page 1647 - Clinical Small Animal Internal Medicine
P. 1647
Index 1585
abnormal hair growth bartonellosis 924 chronic kidney disease 1170–1171
VetBooks.ir anagen/telogen defluxion 1437 kennels and multicat liver disease 652–653
feline leukemia virus 881
1434–1435, 1435
feline leukemia virus 878
alopecia X 1435, 1436
metabolic diseases 680
environments 1064
approach to the dermatologic American College of Cardiology paraneoplastic syndromes
patient 1386 Foundation and American Heart 1219–1220
atopic dermatitis 1406 Association (ACCF/AHA) 177 shock 405
autoimmune and immune‐mediated American College of Clinical anesthesia
skin disease 1424, 1426 Pharmacology (ACCP) 321 esophageal disorders 560–561
bacterial pyodermas 1463–1464 American College of Veterinary mechanical ventilation 397
cutaneous manifestations of systemic Behaviorists (ACVB) 1575 rectoanal diseases 616
disease 1488–1489, 1489 American College of Veterinary surgical, traumatic, and bite wound
cyclic flank alopecia 1436, 1436 Internal Medicine (ACVIM) infections 1031, 1034
diagnosis 1438 canine myocardial disease 254, trauma and burns 451–452
distribution and pattern of 259–262 angioedema 1413–1414, 1414, 1414
alopecia 1437–1438 heart failure 177–178 angiogenesis 1208–1209
ease of epilation 1437 pituitary‐dependent angiography
etiology/pathophysiology hyperadrenocorticism 53 congenital heart disease 240, 242
1433–1437 valvular heart disease 247–250 pleural effusion 342–343
exocrine pancreatic cancer 1293 American Veterinary Dental College pulmonary thromboembolism
hair cycle arrest 1435 (AVDC) 534 319–320
history and clinical American Veterinary Society of angiotensin‐converting enzyme
signs 1437–1438 Animal Behavior (AVSAB) (ACE) 179–180
inflammation‐induced 1575, 1577 angiotensin‐converting enzyme
alopecia 1433, 1434, 1434 amino acid‐derived hormones 30 inhibitors (ACEI)
noninflammatory alopecia aminobisphosphonates (ABP) canine myocardial disease
1434–1437, 1436 1331–1332 259–262
onset of alopecia 1437 aminoglycosides (AG) 957, chronic kidney disease
paraneoplastic syndromes 1041–1044 1168–1170, 1169
1221–1222 AML see acute myeloid leukemia congenital heart disease 240–243
patterned alopecia 1436, 1436 ammonium urate urolithiasis feline myocardial disease 273
postclipping hair follicle 1128–1129, 1128, 1141–1142 glomerular disease 1104–1105
arrest 1436–1437, 1437 amputation 617–618, 1330–1331 heart failure 183, 186, 188–190,
prognosis 1438–1439 amyloidosis 193, 197
signalment 1437 cutaneous manifestations of systemic systemic hypertension 222–224
trauma‐induced alopecia 1433 disease 1483–1484 valvular heart disease 248–250
treatment 1438, 1438 hepatobiliary disease 665–666 angiotensin receptor blockers (ARB)
alpha‐1‐proteinase inhibitors 633 metabolic diseases 680–681 chronic kidney disease
alpha‐agonists 451, 1184 anagen defluxion 1437 1168–1170, 1169
alpha‐fucosidosis 775 analgesia 735 glomerular disease 1104–1105
ALS see advanced life support see also pain and pain management systemic hypertension 222, 224
ALT see alternative lengthening of anal sac adenocarcinoma 609–610 Animal Trauma Triage (ATT)
telomeres anal sacculectomy 610–611 Score 455, 456
alternative lengthening of telomeres anal sac impaction 610–611 anion gap 1092
(ALT) 1206 analysis of variability 9 anisocoria 737, 824
alveolar dead space 383 anaphylactic/anaphylactoid anorexia 255, 679–680
alveolar gas equation 376–377 hypersensitivity reactions Anrep effect 176
amanita mushrooms 684 462–463 antacids see gastroprotectants
amaurosis 823 anaplasmosis see ehrlichiosis and anthrax 971–975
ambulatory 24‐hour Holter anaplasmosis diagnosis 973
recording 213 anatomic shunting see right‐to‐left etiology/pathophysiology 971–972
amebiasis 1019 shunting history and clinical signs 972–973
American Animal Hospital Association ANC see acute neutrophilic cholangitis prevention 974–975
(AAHA) 1064 anemia public health implications 974
American Association of Feline acute kidney injury 1092 signalment 972, 972
Practitioners (AAFP) antimicrobials 1047 treatment 973–974, 973